Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ICON
Dublin, Dublin, Irelandiconplc.com ↗
- Ownership
- Public · ICLR
- Employees
- ~41900
- Development stage
- Commercial
01
Overview
ICON provides full-service clinical research solutions globally, supporting the development of drugs, biologics, devices, and diagnostics. In recent years it supported over a thousand studies annually with notable success in drug approvals for its clients. It has contributed to the development of more than seventy approved drugs.
In FY2024 alone, it supported over forty-seven thousand patients in nearly fifteen hundred studies and contributed to eighteen drug approvals.
The company consistently wins industry awards for excellence in contract research services.
As a service provider/CRO rather than product developer or biotech/pharma company itself, it does not have its own proprietary pipeline.
- Therapeutic areas
- GastroenterologyCardiovascularOphthalmologyEndocrinologyImmunologyWomen's HealthOncologyRare DiseasesNeurologyInfectious Diseases
- Modalities
- Small moleculeBiologicMonoclonal antibodyVaccineMedical device
- Industry
- Contract Research Organization
02
Partnerships
LEO Pharma partnership on dermatology trialsUS Biomedical Advanced Research and Development Authority on anthrax vaccine trialNumerous partnerships with global pharmaceutical/biotech/device companies as part of standard CRO business model
03
Financials
- Market cap
- $15.1B
- Total revenue
- $8.3B
- Enterprise value
- $17.8B
Beyond the preview
Go deeper on ICON.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ICON.